Multiple sclerosis is a progressive condition where the brain and the spinal cord get affected due to damage to the myelin sheath. This further causes a lot of neurological symptoms, such as ...

Tiziana (TLSA) is showing groundbreaking advancements in Alzheimer's & MS treatments with foralumab. Key trials & market ...

Multiple Sclerosis (MS) is a demyelinating disease in which the insulating covers of nerve cells are damaged. Microglia cells (orange) attack the oligodendrocytes that form the insulating myelin ...

World Multiple Sclerosis Day is observed every year on May 30. According to the World Health Organisation (WHO), it is estimated that over 1.8 million people have multiple sclerosis (MS ...

The awards are presented by the International Organization of Multiple Sclerosis Nurses (IOMSN) with support from Merck KGaA, Darmstadt, Germany. The International Nightingale Award was launched ...

Multiple Sclerosis: Cell-Catching Implant Helps Identify Successful Treatment in Mice Feb. 18, 2025 — A sponge-like implant in mice helped guide a treatment that slowed or stopped a degenerative ...

Fighting multiple sclerosis, Colorado woman runs 189 miles from Denver to Nebraska 02:42 While a lot of people are relaxing on Memorial Day weekend, one Colorado woman is spending her week raising ...

William Lindsey, MD, director of the division of multiple sclerosis and neuroimmunology at the University of Texas Health Science Center at Houston. “It involves interactions between diet ...

Among 46,000 MS patients living in temperate zones, more severe disease was seen in those who lived above 40° latitude, reported Tomas Kalincik, MD, PhD, of the University of Melbourne, Australia ...

Basel, 30 May 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today new, 96-week data for fenebrutinib demonstrating that patients with relapsing multiple sclerosis (RMS) maintained no ...

Donald Trump’s gutting of Harvard University’s funding is set to have a ripple effect on Australia’s research into multiple sclerosis at a critical time for studies into the debilitating ...